Enimmune corporation(TW:6564)
NT$14.900.00 (0.00%)
TW:6564
Enimmune corporation Revenue
NT$14.90
At close:0.00 (0.00%)
Enimmune corporation (6564) Revenue
Enimmune corporation Revenue
Enimmune corporation had a revenue of 27.90M in the quarter ending Jun 30, 2026, with 9.19%. This bring the company's revenue in the last twelve months to 53.45M, Increased 10.91%. In the fiscal year ending Dec 31, 2025, Enimmune corporation had annual revenue of 48.19M with 20.74% growth.
- Revenue (ttm)
- 53.45M
- Revenue Growth
- ―
- P/S Ratio
- 25.36
- Revenue/Employee
- TWD 1,784,963
- Employees
- 27
- Market Cap
- TWD 1.22B
Revenue Chart
Enimmune corporation Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 48.19M | 8.28M | 20.74% |
| Dec 31, 2024 | 39.91M | -3.58M | -8.23% |
| Dec 31, 2023 | 43.49M | -144.92M | -76.92% |
| Dec 31, 2022 | 188.41M | 78.59M | 71.56% |
| Dec 31, 2021 | 109.82M | 86.95M | 380.08% |
| Dec 31, 2020 | 22.88M | 20.93M | 1076.75% |
| Dec 31, 2019 | 1.94M | 785.00K | 67.73% |
| Dec 31, 2018 | 1.16M | -541.00K | -31.82% |
| Dec 31, 2017 | 1.70M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.